Advertisement
Advertisement

KAPA

KAPA logo

Kairos Pharma, Ltd.

0.46
USD
Sponsored
+0.01
+2.47%
Jun 17, 15:59 UTC -4
Closed
exchange

After-Market

0.45

-0.01
-1.31%

KAPA Earnings Reports

Positive Surprise Ratio

KAPA beat 0 of 7 last estimates.

0%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Kairos Pharma, Ltd. earnings per share and revenue

On May 13, 2026, KAPA reported earnings of -0.08 USD per share (EPS) for Q1 26, missing the estimate of -0.07 USD, resulting in a -4.58% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +6.10% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
logo
Greenwich LifeSciences, Inc.
Report Date
Jun 04, 2026 For Q1 26
Estimate
-$0.33
Actual
-$0.39
Surprise
-15.86%
FAQ
For Q1 2026, Kairos Pharma, Ltd. reported EPS of -$0.08, missing estimates by -4.58%, and revenue of $0.00, 0% as expectations.
The stock price moved up 6.1%, changed from $0.46 before the earnings release to $0.49 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Kairos Pharma, Ltd. is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement